Nuclear Receptor ROR-Gamma Market Report

China Nuclear Receptor ROR-Gamma Industry Market Research Report 2023-2029

  • POSTDATE：Oct 03, 2023
  • PAGES：141
  • REPORT CODE：GMM1821546
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Nuclear Receptor ROR-Gamma industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Celgene Corporation

    • 4SC AG

    • GlaxoSmithKline Plc

    • Visionary Pharmaceuticals, Inc

    • Nuevolution AB

    • Brickell Biotech, Inc

    • Aurigene Discovery Technologies Limited

    • Arrien Pharmaceuticals, LLC

    • Teijin Pharma Limited

    • Genfit SA

    • Vitae Pharmaceuticals, Inc

    • Advinus Therapeutics Ltd

    • Biogen, Inc

    • Reata Pharmaceuticals, Inc

    • Karo Bio AB

    • Hanmi Pharmaceuticals, Co Ltd

    • Bristol-Myers Squibb Company

    By Type:

    • INV-17

    • VPR-66

    • GSK-2981278

    • Others

    • BBI-6000

    By Application:

    • Others

    • Hospital

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Nuclear Receptor ROR-Gamma Market Overview 2018-2029

    • 1.1 China Nuclear Receptor ROR-Gamma Industry Development Overview

    • 1.2 China Nuclear Receptor ROR-Gamma Industry Development History

    • 1.3 China Nuclear Receptor ROR-Gamma Industry Market Size (2018-2029)

    • 1.4 China Nuclear Receptor ROR-Gamma Market Analysis by Type from Production Side

      • 1.4.1 China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of INV-17 (2018-2029)

      • 1.4.2 China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of VPR-66 (2018-2029)

      • 1.4.3 China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of GSK-2981278 (2018-2029)

      • 1.4.4 China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.5 China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of BBI-6000 (2018-2029)

    • 1.5 China Nuclear Receptor ROR-Gamma Market Analysis by Application from Consumption End

      • 1.5.1 China Nuclear Receptor ROR-Gamma Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Nuclear Receptor ROR-Gamma Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.3 China Nuclear Receptor ROR-Gamma Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China Nuclear Receptor ROR-Gamma Market Analysis by Region

      • 1.6.1 North China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

    Chapter 2 China Nuclear Receptor ROR-Gamma Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Nuclear Receptor ROR-Gamma Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Nuclear Receptor ROR-Gamma Market Status and Competition Analysis in 2023

      • 2.2.3 China Nuclear Receptor ROR-Gamma Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Nuclear Receptor ROR-Gamma Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Nuclear Receptor ROR-Gamma Industry Development

    Chapter 3 Nuclear Receptor ROR-GammaIndustry Chain Analysis

    • 3.1 Nuclear Receptor ROR-Gamma Industry Chain

    • 3.2 Nuclear Receptor ROR-Gamma Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Nuclear Receptor ROR-Gamma Market

    • 3.3 Nuclear Receptor ROR-Gamma Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Nuclear Receptor ROR-Gamma Market

    Chapter 4 China Nuclear Receptor ROR-Gamma Market, by Type

    • 4.1 China Nuclear Receptor ROR-Gamma Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Nuclear Receptor ROR-Gamma Total Production Volume and Growth Rate from Production Side

    • 4.5 China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate, by Type

      • 4.5.1 China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of INV-17

      • 4.5.2 China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of VPR-66

      • 4.5.3 China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of GSK-2981278

      • 4.5.4 China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of Others

      • 4.5.5 China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of BBI-6000

    Chapter 5 China Nuclear Receptor ROR-Gamma Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Nuclear Receptor ROR-Gamma Total Market Size and Growth Rate from Consumption End

    • 5.5 China Nuclear Receptor ROR-Gamma Market Size and Growth Rate, by Application

      • 5.5.1 China Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Others

      • 5.5.2 China Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Hospital

      • 5.5.3 China Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Clinic

    Chapter 6 China Nuclear Receptor ROR-Gamma Market, by Region

    • 6.1 China Nuclear Receptor ROR-Gamma Production Volume and Production Value, by Region

    • 6.2 China Nuclear Receptor ROR-Gamma Sales Volume and Sales Value, by Region

    Chapter 7 North China Nuclear Receptor ROR-Gamma Market Analysis

    • 7.1 North China Nuclear Receptor ROR-Gamma Market, by Type

    • 7.2 North China Nuclear Receptor ROR-Gamma Market, by Application

    Chapter 8 Central China Nuclear Receptor ROR-Gamma Market Analysis

    • 8.1 Central China Nuclear Receptor ROR-Gamma Market, by Type

    • 8.2 Central China Nuclear Receptor ROR-Gamma Market, by Application

    Chapter 9 South China Nuclear Receptor ROR-Gamma Market Analysis

    • 9.1 South China Nuclear Receptor ROR-Gamma Market, by Type

    • 9.2 South China Nuclear Receptor ROR-Gamma Market, by Application

    Chapter 10 East China Nuclear Receptor ROR-Gamma Market Analysis

    • 10.1 East China Nuclear Receptor ROR-Gamma Market, by Type

    • 10.2 East China Nuclear Receptor ROR-Gamma Market, by Application

    Chapter 11 Northeast China Nuclear Receptor ROR-Gamma Market Analysis

    • 11.1 Northeast China Nuclear Receptor ROR-Gamma Market, by Type

    • 11.2 Northeast China Nuclear Receptor ROR-Gamma Market, by Application

    Chapter 12 Southwest China Nuclear Receptor ROR-Gamma Market Analysis

    • 12.1 Southwest China Nuclear Receptor ROR-Gamma Market, by Type

    • 12.2 Southwest China Nuclear Receptor ROR-Gamma Market, by Application

    Chapter 13 Northwest China Nuclear Receptor ROR-Gamma Market Analysis

    • 13.1 Northwest China Nuclear Receptor ROR-Gamma Market, by Type

    • 13.2 Northwest China Nuclear Receptor ROR-Gamma Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Celgene Corporation

        • 14.1.1 Celgene Corporation Company Profile

        • 14.1.2 Celgene Corporation Nuclear Receptor ROR-Gamma Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 4SC AG

        • 14.2.1 4SC AG Company Profile

        • 14.2.2 4SC AG Nuclear Receptor ROR-Gamma Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 GlaxoSmithKline Plc

        • 14.3.1 GlaxoSmithKline Plc Company Profile

        • 14.3.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Visionary Pharmaceuticals, Inc

        • 14.4.1 Visionary Pharmaceuticals, Inc Company Profile

        • 14.4.2 Visionary Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Nuevolution AB

        • 14.5.1 Nuevolution AB Company Profile

        • 14.5.2 Nuevolution AB Nuclear Receptor ROR-Gamma Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Brickell Biotech, Inc

        • 14.6.1 Brickell Biotech, Inc Company Profile

        • 14.6.2 Brickell Biotech, Inc Nuclear Receptor ROR-Gamma Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Aurigene Discovery Technologies Limited

        • 14.7.1 Aurigene Discovery Technologies Limited Company Profile

        • 14.7.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Arrien Pharmaceuticals, LLC

        • 14.8.1 Arrien Pharmaceuticals, LLC Company Profile

        • 14.8.2 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Teijin Pharma Limited

        • 14.9.1 Teijin Pharma Limited Company Profile

        • 14.9.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Genfit SA

        • 14.10.1 Genfit SA Company Profile

        • 14.10.2 Genfit SA Nuclear Receptor ROR-Gamma Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Vitae Pharmaceuticals, Inc

        • 14.11.1 Vitae Pharmaceuticals, Inc Company Profile

        • 14.11.2 Vitae Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Advinus Therapeutics Ltd

        • 14.12.1 Advinus Therapeutics Ltd Company Profile

        • 14.12.2 Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Biogen, Inc

        • 14.13.1 Biogen, Inc Company Profile

        • 14.13.2 Biogen, Inc Nuclear Receptor ROR-Gamma Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Reata Pharmaceuticals, Inc

        • 14.14.1 Reata Pharmaceuticals, Inc Company Profile

        • 14.14.2 Reata Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Karo Bio AB

        • 14.15.1 Karo Bio AB Company Profile

        • 14.15.2 Karo Bio AB Nuclear Receptor ROR-Gamma Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Hanmi Pharmaceuticals, Co Ltd

        • 14.16.1 Hanmi Pharmaceuticals, Co Ltd Company Profile

        • 14.16.2 Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Bristol-Myers Squibb Company

        • 14.17.1 Bristol-Myers Squibb Company Company Profile

        • 14.17.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Market Performance

        • 14.17.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Nuclear Receptor ROR-Gamma Industry Research Conclusions

    • 15.2 Nuclear Receptor ROR-Gamma Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Nuclear Receptor ROR-Gamma Industry Market Size (2018-2029)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of INV-17 (2018-2029)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of VPR-66 (2018-2029)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of GSK-2981278 (2018-2029)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume, Production Value and Growth Rate of BBI-6000 (2018-2029)

    • Figure China Nuclear Receptor ROR-Gamma Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Nuclear Receptor ROR-Gamma Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Nuclear Receptor ROR-Gamma Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

    • Figure Central China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

    • Figure South China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

    • Figure East China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Nuclear Receptor ROR-Gamma Market Size and Growth Rate from 2018-2029

    • Figure Nuclear Receptor ROR-Gamma Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Nuclear Receptor ROR-Gamma Market Share by Type in 2018

    • Figure China Nuclear Receptor ROR-Gamma Market Share by Type in 2023

    • Figure China Nuclear Receptor ROR-Gamma Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of INV-17 (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of VPR-66 (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of GSK-2981278 (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume and Growth Rate of BBI-6000 (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Market Share by Application in 2018

    • Figure China Nuclear Receptor ROR-Gamma Market Share by Application in 2023

    • Figure China Nuclear Receptor ROR-Gamma Total Market Size and Growth Rate from Consumption End

    • Figure China Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Others (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Market Size and Growth Rate of Clinic (2018-2023)

    • Table China Nuclear Receptor ROR-Gamma Production Volume by Region (2018-2023)

    • Table China Nuclear Receptor ROR-Gamma Production Volume Share by Region (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Production Volume Share by Region (2018-2023)

    • Table China Nuclear Receptor ROR-Gamma Production Value by Region (2018-2023)

    • Table China Nuclear Receptor ROR-Gamma Production Value Share by Region (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Production Value Share by Region (2018-2023)

    • Table China Nuclear Receptor ROR-Gamma Sales Volume by Region (2018-2023)

    • Table China Nuclear Receptor ROR-Gamma Sales Volume Share by Region (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Sales Volume Share by Region (2018-2023)

    • Table China Nuclear Receptor ROR-Gamma Sales Value by Region (2018-2023)

    • Table China Nuclear Receptor ROR-Gamma Sales Value Share by Region (2018-2023)

    • Figure China Nuclear Receptor ROR-Gamma Sales Value Share by Region (2018-2023)

    • Table North China Nuclear Receptor ROR-Gamma Production Volume by Type (2018-2023)

    • Table North China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Figure North China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Table North China Nuclear Receptor ROR-Gamma Sales Volume by Application (2018-2023)

    • Table North China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Figure North China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Table Central China Nuclear Receptor ROR-Gamma Production Volume by Type (2018-2023)

    • Table Central China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Figure Central China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Table Central China Nuclear Receptor ROR-Gamma Sales Volume by Application (2018-2023)

    • Table Central China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Figure Central China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Table South China Nuclear Receptor ROR-Gamma Production Volume by Type (2018-2023)

    • Table South China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Figure South China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Table South China Nuclear Receptor ROR-Gamma Sales Volume by Application (2018-2023)

    • Table South China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Figure South China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Table East China Nuclear Receptor ROR-Gamma Production Volume by Type (2018-2023)

    • Table East China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Figure East China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Table East China Nuclear Receptor ROR-Gamma Sales Volume by Application (2018-2023)

    • Table East China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Figure East China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Table Northeast China Nuclear Receptor ROR-Gamma Production Volume by Type (2018-2023)

    • Table Northeast China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Figure Northeast China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Table Northeast China Nuclear Receptor ROR-Gamma Sales Volume by Application (2018-2023)

    • Table Northeast China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Table Southwest China Nuclear Receptor ROR-Gamma Production Volume by Type (2018-2023)

    • Table Southwest China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Figure Southwest China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Table Southwest China Nuclear Receptor ROR-Gamma Sales Volume by Application (2018-2023)

    • Table Southwest China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Table Northwest China Nuclear Receptor ROR-Gamma Production Volume by Type (2018-2023)

    • Table Northwest China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Figure Northwest China Nuclear Receptor ROR-Gamma Production Volume Share by Type (2018-2023)

    • Table Northwest China Nuclear Receptor ROR-Gamma Sales Volume by Application (2018-2023)

    • Table Northwest China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Nuclear Receptor ROR-Gamma Sales Volume Share by Application (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table 4SC AG Company Profile

    • Table 4SC AG Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Plc Company Profile

    • Table GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Visionary Pharmaceuticals, Inc Company Profile

    • Table Visionary Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Nuevolution AB Company Profile

    • Table Nuevolution AB Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Brickell Biotech, Inc Company Profile

    • Table Brickell Biotech, Inc Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Aurigene Discovery Technologies Limited Company Profile

    • Table Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Arrien Pharmaceuticals, LLC Company Profile

    • Table Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Teijin Pharma Limited Company Profile

    • Table Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Genfit SA Company Profile

    • Table Genfit SA Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Vitae Pharmaceuticals, Inc Company Profile

    • Table Vitae Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Advinus Therapeutics Ltd Company Profile

    • Table Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Biogen, Inc Company Profile

    • Table Biogen, Inc Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Reata Pharmaceuticals, Inc Company Profile

    • Table Reata Pharmaceuticals, Inc Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Karo Bio AB Company Profile

    • Table Karo Bio AB Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Hanmi Pharmaceuticals, Co Ltd Company Profile

    • Table Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US